The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Induction of tumor cell-based ADCC resistance to create new tumor cell survival and therapy resistance mechanisms.
 
Dalal S. Aldeghaither
No Relationships to Disclose
 
Joseph C. Murray
No Relationships to Disclose
 
Sarah Martinez Roth
No Relationships to Disclose
 
Elana J. Fertig
No Relationships to Disclose
 
Shaojun Tang
No Relationships to Disclose
 
Sandra A Jablonski
No Relationships to Disclose
 
Louis M. Weiner
Stock and Other Ownership Interests - Celldex; CytomX Therapeutics; Jounce Therapeutics; Merrimack
Consulting or Advisory Role - Abbvie; CytomX Therapeutics; Immunome; Novartis; Sandoz
Research Funding - Symphony Evolution
Patents, Royalties, Other Intellectual Property - Patent licensed to Merrimack Pharmaceuticals
Expert Testimony - Abbvie